Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Accounts Payables (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Accounts Payables for 3 consecutive years, with $116.2 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 13.46% to $116.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $116.2 million through Dec 2025, up 13.46% year-over-year, with the annual reading at $116.2 million for FY2025, 13.46% up from the prior year.
  • Accounts Payables hit $116.2 million in Q4 2025 for Guardian Pharmacy Services, down from $121.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $121.7 million in Q3 2025 to a low of $85.6 million in Q4 2023.
  • Historically, Accounts Payables has averaged $105.6 million across 3 years, with a median of $105.0 million in 2025.
  • Biggest five-year swings in Accounts Payables: increased 19.65% in 2024 and later rose 13.46% in 2025.
  • Year by year, Accounts Payables stood at $85.6 million in 2023, then increased by 19.65% to $102.4 million in 2024, then grew by 13.46% to $116.2 million in 2025.
  • Business Quant data shows Accounts Payables for GRDN at $116.2 million in Q4 2025, $121.7 million in Q3 2025, and $105.0 million in Q2 2025.